We identified a dedicated axis of the NF-κB pathway, mediated by GADD45β, which integrates the NF-κB-dependent mechanism suppressing tumour-cell apoptosis with that governing tumour-based inflammation [4, 6]. Here, NFKB1 is linked to neoplasm.